Viewing Study NCT04450069

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2026-05-16 @ 12:17 PM
Study NCT ID: NCT04450069
Status: COMPLETED
Last Update Posted: 2024-08-20
First Post: 2020-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies
Sponsor: Calibr, a division of Scripps Research
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed/Refractory B-cell Lymphomas View
None Diffuse Large B Cell Lymphoma (DLBCL) View
None Follicular Lymphoma (FL) View
None Chronic Lymphocytic Leukemia (CLL) View
None Marginal Zone Lymphoma (MZL) View
None Mantle Cell Lymphoma View
None Small Lymphocytic Lymphoma (SLL) View
None Primary Mediastinal Large B Cell Lymphoma View
None Transformed Follicular Lymphoma View
None Waldenstrom Macroglobulinemia View
None Lymphoplasmacytic Lymphoma View
None Burkitt Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR-T Cell Therapy View
None Switchable CAR-T Cell View
None Autologous Cell Therapy View
None CD19 Positive Disease View
None CD19 CAR-T Cell View
None Blood Cancer View
None Hematological malignancy View
None Neoplasms View